PGEN Stock Analysis

PGEN -  USA Stock  

USD 6.35  0.01  0.16%

The latest slide in stock price may encourage institutional investors to take a closer look at the company as it is trading at a share price of 6.35 on 4,468,700 in trading volume. The company directors and management have failed to build on market volatilities in May. However, diversifying your overall positions with Precigen may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.0. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Precigen partners.
Please check Your Equity Center.

Search Stock Analysis 

The Precigen stock analysis report makes it easy to digest most publicly released information about Precigen and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. PGEN stock analysis module also helps to analyze the Precigen price relationship with some important fundamental indicators such as market cap and management efficiency.

PGEN Stock Analysis Notes

About 14.0% of the company outstanding shares are owned by corporate insiders. The book value of Precigen was at this time reported as 3.47. The company recorded a loss per share of 4.88. Precigen had not issued any dividends in recent years. Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. Precigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 423 people. To find out more about Precigen contact the company at 301 556 9900 or learn more at

Precigen Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Precigen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Precigen or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Precigen generates negative expected return over the last 90 days
Precigen has high historical volatility and very poor performance
The company reported the previous year's revenue of 97.85 M. Net Loss for the year was (104.77 M) with profit before overhead, payroll, taxes, and interest of 6.02 M.
Precigen currently holds about 105.69 M in cash with (65.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Roughly 71.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Sale by Ares Trading Sa of 55541 shares of Precigen

Precigen Upcoming and Recent Events

Earnings reports are used by Precigen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Precigen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report27th of February 2020
Next Earnings Report14th of May 2020
Next Fiscal Quarter End31st of December 2019
Next Fiscal Year End27th of February 2020
Last Quarter Report30th of September 2019
Last Earning Announcement31st of December 2018

PGEN Largest EPS Surprises

Earnings surprises can significantly impact Precigen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

PGEN Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Precigen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Precigen backward and forwards among themselves. Precigen's institutional investor refers to the entity that pools money to purchase Precigen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Third Security LlcCommon Shares81.8 M563.3 M
Miller Value Partners LlcCommon Shares9.1 M62.7 M
Vanguard Group IncCommon Shares8.7 M60.2 M
Blackrock IncCommon Shares7.4 M50.8 M
Iridian Asset Management LlcCommon Shares7.4 M50.7 M
State Street CorpCommon Shares6.9 M47.4 M
Citadel Advisors LlcDebt44.1 M36.6 M
Geode Capital Management LlcCommon Shares1.5 M10.3 M
Note, although Precigen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PGEN Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Precigen's market, we take the total number of its shares issued and multiply it by Precigen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

PGEN Profitablity

Precigen's profitability indicators refer to fundamental financial ratios that showcase Precigen's ability to generate income relative to its revenue or operating costs. If, let's say, Precigen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Precigen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Precigen's profitability requires more research than a typical breakdown of Precigen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (134.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (89.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.89.

Management Efficiency

The entity has return on total asset (ROA) of (13.45) % which means that it has lost $13.45 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (79.97) %, meaning that it created substantial loss on money invested by shareholders. Precigen management efficiency ratios could be used to measure how well precigen manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 19th of June, Precigen holds the risk adjusted performance of (0.06), and Coefficient Of Variation of (939.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Precigen, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Precigen, which can be compared to its competitors. Please check Precigen information ratio, as well as the relationship between the potential upside and kurtosis to decide if Precigen is priced some-what accurately, providing market reflects its current price of 6.35 per share. Given that Precigen has jensen alpha of (0.46), we recommend you to check out Precigen's recent market performance to make sure the company can sustain itself at a future point.

Precigen Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. View also all equity analysis or get more info about mavp overlap studies indicator.

Precigen Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precigen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precigen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Precigen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Precigen Predictive Daily Indicators

Precigen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Precigen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Precigen Forecast Models

Precigen time-series forecasting models is one of many Precigen's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Precigen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Precigen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Precigen stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PGEN shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Precigen. By using and applying PGEN Stock analysis, traders can create a robust methodology for identifying PGEN entry and exit points for their positions.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. Precigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 423 people.

Current PGEN Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PGEN analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PGEN analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Precigen current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most PGEN analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand PGEN stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Precigen, talking to its executives and customers, or listening to PGEN conference calls.
PGEN Analyst Advice Details

PGEN Stock Analysis Indicators

Precigen stock analysis indicators help investors evaluate how Precigen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Precigen shares will generate the highest return on investment. By understating and applying Precigen stock analysis, traders can identify Precigen position entry and exit signals to maximize returns.
Quick Ratio5.03
Fifty Two Week Low3.36
Revenue Growth-17.90%
Shares Short Prior Month26.95M
Average Daily Volume Last 10 Day2.63M
Average Daily Volume In Three Month1.36M
Shares Percent Shares Out11.83%
Gross Margins2.20%
Short Percent Of Float25.99%
Forward Price Earnings-11.75
Float Shares77.11M
Fifty Two Week High11.10
Enterprise Value To Ebitda-20.27
Fifty Day Average6.94
Two Hundred Day Average8.02
Enterprise Value To Revenue15.04
Please check Your Equity Center. Note that the Precigen information on this page should be used as a complementary analysis to other Precigen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Precigen Stock analysis

When running Precigen price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
The market value of Precigen is measured differently than its book value, which is the value of PGEN that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine Precigen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.